The effects of palonoserton on postoperative nausea and vomiting(PONV) in total knee arthroplasty.

Trial Profile

The effects of palonoserton on postoperative nausea and vomiting(PONV) in total knee arthroplasty.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 31 May 2017

At a glance

  • Drugs Palonosetron (Primary)
  • Indications Nausea and vomiting
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top